Sonova (SOON) Investor & Analyst Day 2024 summary

Strategic direction and market outlook

• Maintains long-term growth ambition with 6–9% revenue and 7–11% EBITDA/EBITA mid-term targets, unchanged from prior guidance despite Q1 market softness.

• Strategy focuses on innovation, expanding consumer access, omni-channel care, and continuous process improvement, with proven pillars and process optimization.

• U.S. and Canadian markets show robust long-term growth, though U.S. commercial growth slowed and managed care is normalizing; Europe is mixed, with Germany stable and France/UK lagging.

• FY 2024/25 outlook confirmed: expects 6–9% sales growth and 7–11% EBITA growth in local currency, with stronger 2H expected as launch costs and ASP pressure ease.

• Key growth drivers include hearing innovation, digital transformation, and investments in high-growth markets.

Breakthrough innovation and product launches

• Launched Infinio and Sphere Infinio platforms, featuring proprietary Era and DeepSonic AI chips, delivering up to 10 dB SNR improvement and real-time DNN speech-from-noise separation.

• Sphere Infinio is the first hearing aid with a dedicated AI chip, enabling significant technological advancement and a 2–3 year lead over competitors.

• Clinical studies show Sphere Infinio users are 2–3 times more likely to understand speech in noise, with up to 50% more access to speech cues than competitors.

• Infinio platform advances sound quality, connectivity, reliability, and personalization, with features like AI-based fitting, robust Bluetooth/Auracast compatibility, and 93% consumer satisfaction at first fit.

• Initial U.S. demand for Sphere Infinio has exceeded expectations, reversing original product mix assumptions and generating strong market response.

Manufacturing, supply, and financial implications

• Manufacturing complexity for Sphere Infinio is only marginally higher than Infinio, with current capacity sufficient for 2024 demand; further investment planned if growth continues.

• Launch costs, marketing expenses, and ASP pressure are concentrated in H1, with profitability expected to be significantly higher in H2.

• Swiss franc strength presents a 1–2% revenue and 3–4% EBITDA headwind if current rates persist.

• Sphere Infinio carries a price premium over Infinio, reflecting higher R&D and component costs, but is positioned for higher-end market segments.

• Restructuring and integration costs for FY 2024/25 estimated at CHF 30–40 million; currency headwinds to reduce reported growth.